• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

WellSync Partners With Marius to Offer Oral TRT Treatment on Digital Platform

News
Article

Users of the platform will have access to Kyzatrex.

Stock.adobe.com

Stock.adobe.com

WellSync is collaborating with Marius Pharmaceuticals to offer a testosterone replacement therapy (TRT) option on the WellSync digital platform.1 Thanks to the partnership, people using the platform will have access to Kyzatrex, an oral TRT treatment approved by FDA.

In a press release, WellSync CEO Clint House said, “Our work with Marius Pharmaceuticals represents a significant step forward in our mission to transform the way healthcare is delivered. By offering Kyzatrex through our virtual care platform, we're delivering a streamlined, accessible, and effective solution for men's health that seamlessly integrates into our clients' existing offerings. Additionally, we're creating a new marketplace for brand manufacturers to leverage our platform to launch their innovative treatments. With the growing demand for health and wellness solutions, particularly in light of the GLP-1 trend, adding this new Kyzatrex low T treatment to our clients' programs perfectly complements our goal of improving access to care while supporting innovative medications that are poised to leverage our direct-to-consumer platform. This collaboration with Marius Pharmaceuticals underscores our commitment to working with leading pharmaceutical companies to bring cutting-edge treatments directly to patients, enhancing their health and well-being."

Marius Pharmaceuticals CEO Shalin Shah added, “At Marius, we prioritize making therapies more accessible to patients. By offering Kyzatrex through WellSync's platform, we're simplifying the process for men to manage their testosterone levels. This effort is an important step toward enhancing healthcare accessibility and improving patient outcomes."

This is just the latest move by WellSync to improve patient access to this particular TRT treatment. Earlier this month, the company announced that it had also partnered with Vitamin Shoppe in order to make Kyzatrex available on its telehealth platform.2

In a press release issued at the time, House said, “WellSync is driving the future of telehealth innovation, transforming the connection between providers and patients by seamlessly modernizing healthcare delivery through the integration of clinical protocols into their online platform. We are thrilled to deepen our partnership with The Vitamin Shoppe by introducing hormone replacement therapy, including Marius Pharmaceuticals' Kyzatrex oral testosterone treatment for men. This new offering reinforces our shared commitment to delivering high-quality, accessible healthcare solutions that greatly enhance consumers' overall health and well-being."

WellSync first announced its general partnership with Vitamin Shoppe in May of this year.3 At the time, House said, “Our partnership with The Vitamin Shoppe is a testament to WellSync's dedication to providing adaptable and seamless virtual health solutions. By leveraging our extensive network of vetted clinician and pharmacy partners, we ensure a reliable supply of GLP-1 medications, even amid potential shortages. This collaboration not only maximizes patient and provider choice but also reinforces our shared mission to offer accessible, personalized care."

Source

  1. WellSync and Marius Pharmaceuticals Collaborate to Offer FDA-approved Oral Testosterone Replacement Therapy, Expanding Virtual Care for Men's Health. WellSync. September 9, 2024. https://www.prnewswire.com/news-releases/wellsync-and-marius-pharmaceuticals-collaborate-to-offer-fda-approved-oral-testosterone-replacement-therapy-expanding-virtual-care-for-mens-health-302239537.html
  2. WellSync Expands Partnership with The Vitamin Shoppe® to Power Testosterone Replacement Therapy on Whole Health Rx Telehealth Platform. WellSync. September 4, 2024. https://www.prnewswire.com/news-releases/wellsync-expands-partnership-with-the-vitamin-shoppe-to-power-testosterone-replacement-therapy-on-whole-health-rx-telehealth-platform-302238147.html
  3. WellSync Powers The Vitamin Shoppe's New Whole Health Rx Telehealth Service. WellSync. May 17, 2024. Accessed September 9, 2024. https://www.prnewswire.com/news-releases/wellsync-powers-the-vitamin-shoppes-new-whole-health-rx-telehealth-service-302148171.html
Recent Videos
Related Content